Pura Vida Investments, LLC Macrogenics Inc Call Options Transaction History

Pura Vida Investments, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 16, 2021	SELL	$20.49 - $35.63 $3.59 Million - $6.24 Million	-175,000 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$18.99 - $33.2 $3.32 Million - $5.81 Million	175,000 New	175,000 $5.57 Million
Q2 2019 Aug 14, 2019	SELL	$14.51 - $19.71 $195,885 - $266,085	-13,500 Closed	0 $0
Q1 2019 Feb 12, 2021	BUY	$11.11 - $25.6 $148,485 - $342,144	13,365 Added 9900.0%	13,500 $243,000
Q1 2019 May 14, 2019	BUY	$11.11 - $25.6 $1,499 - $3,456	135 New	135 $44,000

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.